Business
Press Release Mar 16 2024
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 16, 2024, titled "Zydus receives final approval from USFDA and 180 days CGT exclusivity for Finasteride and Tadalafil Cap Capsules".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 16, 2024, titled \"Zydus receives final approval from USFDA and 180 days CGT exclusivity for Finasteride and Tadalafil Cap Capsules\". View Attachment","length":377,"tagName":"div"}]